Rossari Biotech Schedules Q4 FY26 Earnings Conference Call for April 28, 2026

Rossari biotech Limited has announced an earnings conference call for investors and analysts to discuss its Q4 FY26 financial results. The speciality chemicals manufacturer filed the intimation with stock exchanges under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Conference Call Details

The earnings conference call has been scheduled with specific timing and format details for participant convenience.

Parameter:	Details
Date:	Tuesday, April 28, 2026
Time:	5:00 PM IST
Meeting Type:	Conference Call - Group Meet (Telecommunication)
Participants:	Investors and Analyst Group
Results Declaration:	Monday, April 27, 2026

Call Structure and Management Participation

The conference call will begin with a brief management discussion covering the financial results for both the quarter and financial year ended March 31, 2026. Following the management presentation, participants will have the opportunity to engage in an interactive Question & Answer session. The company's senior management team will be present to address queries and provide insights into the quarterly performance.

Dial-in Information

Rossari Biotech has provided comprehensive access details for participants to join the earnings call.

Access Method:	Details
Universal Dial-in:	+91 22 6280 1141 / 7115 8042
Pre-registration:	Available for zero wait time
Registration Benefit:	Direct connection without operator wait

The company has enabled pre-registration functionality to allow participants to connect directly to the conference call without waiting for an operator, ensuring smooth access to the earnings discussion.

Company Background

Rossari Biotech Limited operates as a speciality chemicals manufacturer, providing intelligent and sustainable solutions across multiple industries. The Mumbai-headquartered company maintains strategically located manufacturing facilities at Silvassa and Dahej. The company's product portfolio spans Home, Personal Care and Performance chemicals (HPPC), Textile speciality chemicals, and Animal Health and Nutrition (AHN) segments, serving applications across FMCG, industrial cleaning, personal care, textile speciality chemicals, performance chemicals, animal health and nutrition, and pet care businesses.

1 Day	5 Days	1 Month	6 Months	1 Year	5 Years
-0.08%	+15.33%	+24.61%	-20.82%	-26.04%	-53.27%

Rossari Biotech Limited has disclosed that its material subsidiary, Unitop Chemicals Private Limited, has approved the sale of office premises in Mumbai for Rs 10 crores. The transaction was approved by the subsidiary's Board of Directors on April 03, 2026, marking a significant asset divestment for the group.

Transaction Details

The subsidiary has agreed to sell its office premises located at Saki Naka, Mumbai at a consideration of approximately Rs 10 crores (Rupees Ten Crore only). The proposed transaction is expected to reach completion by the end of Q2 FY27, providing a clear timeline for the asset disposal.

Parameter:	Details
Property Location:	Saki Naka, Mumbai
Sale Consideration:	Rs 10 crores
Approval Date:	April 03, 2026
Expected Completion:	End of Q2 FY27
Approving Authority:	Board of Directors of Unitop Chemicals Private Limited

Operational Impact Assessment

The company has provided assurance regarding the transaction's impact on business operations. As no business operations are currently conducted from the premises proposed to be sold by the subsidiary, the sale will not have any impact on either the company's or subsidiary's business operations. This strategic decision appears to be focused on asset optimization rather than operational restructuring.

Regulatory Compliance

The disclosure has been made pursuant to Regulation 30(9) read with Schedule III of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company has confirmed that the sale of the premises does not constitute the sale of an undertaking within the meaning of Section 180(1)(a) of the Companies Act, 2013.

Additional details required under Regulation 30 of the Listing Regulations, as per SEBI Master Circular no. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026, will be provided upon execution of the agreement. This ensures full regulatory compliance throughout the transaction process.

Corporate Structure Context

Unitop Chemicals Private Limited operates as a material subsidiary of Rossari Biotech Limited, making this transaction significant enough to warrant disclosure under regulatory requirements. The parent company maintains its registered office at Rossari House, Golden Oak, LBS Marg, Surya Nagar, Vikhroli (West), Mumbai, with manufacturing facilities in Silvassa and Gujarat.